Shanghai Medicilon Inc. (SHSE:688202) announces a share repurchase program. Under the program, the company will repurchase up to CNY 20 million worth of its shares. The shares will be purchased at a price not exceeding CNY 60 per share.

The repurchased shares will be used for equity incentives or employee compensation at an appropriate time in the future. The program will be funded from company's own funds. The program will be valid for 6 months.